Results 181 to 190 of about 99,950 (263)

Cauda equina neuroendocrine tumor: Report of a rare case

Asian Journal of Surgery
Guoyun Zhao, Zhengliang Fan, Qinghua Zou, Rong Yang   +3 more
doaj   +1 more source

Predictors of disease progression in pancreatic neuroendocrine tumors after surgery. [PDF]

Updates Surg
Dobrindt EM, Krömer JM, Mogl MT, Dukaczewska A, Müller-Debus CF, Steinhagen P, Fehrenbach U, Malinka T, Pratschke J, Butz F.   +9 more
europepmc   +1 more source

Nanobodies as next‐generation targeting platforms: From discovery technologies to translational biomedicine

VIEW, EarlyView.
Nanobodies, derived from the variable domains of camelid heavy‐chain‐only antibodies, have emerged as transformative biomedical tools due to their nanoscale size, exceptional stability, and unique capacity to recognize cryptic epitopes. This review provides a comprehensive overview of the field, outlining the structural and biochemical features of ...
Zhenrui Ye, Xianyang Li, Meixiao Zhan
wiley   +1 more source

Cost savings associated with the adoption of lower-dose everolimus in patients with advanced neuroendocrine tumors. [PDF]

ESMO Gastrointest Oncol
de Almeida GR, Riechelmann RP, Brito AB, Taboada RG, da Silva ALM, Weschenfelder RF, Etges APBS.   +6 more
europepmc   +1 more source

Neuroendocrine tumors of the liver

The Korean Journal of Hepatology, 2009
openaire   +2 more sources

Outcomes in Orbit‐Sparing Versus Orbit‐Sacrificing Surgery for Sinonasal Malignancies With Orbital Involvement: A Systematic Review and Meta‐Analysis

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Background Sinonasal malignancies with orbital involvement may be managed with orbit‐sacrificing or orbit‐preserving surgical approaches, with a recent shift towards orbital preservation to reduce postoperative morbidity while maintaining oncological success.
Claire Jing‐Wen Tan, Brian Sheng Yep Yeo, Manish Warrier, Jun He Chan, Lu Hui Png, Shuhui Xu, Kimberley LiQin Kiong, Edward C. Kuan, Tze Choong Charn, Neville Wei Yang Teo   +9 more
wiley   +1 more source

Survival Outcomes in Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis of Progression-Related Endpoints. [PDF]

Cancers (Basel)
Neculai-Candea LS, Caloian AD, Deacu S, Cristian M, Mazilu L, Ilie-Petrov AC, Nitu RA, Ciufu CA, Ciufu N.   +8 more
europepmc   +1 more source

Neuroendocrine Carcinoma of the Head and Neck: A Two‐Decade Institutional Experience

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objectives Primary neuroendocrine carcinoma (NEC) of the head and neck is rare (< 1% of cases) and aggressive, with poorly defined management strategies. This study evaluated clinical characteristics, treatment patterns, and survival outcomes in a single‐institution cohort, identifying factors associated with improved survival.
Micah K. Harris, Katie M. Carlson, Nathan Lu, Anthony Tang, Matthew E. Spector, Joshua D. Smith, Jessica H. Maxwell, Kevin J. Contrera, Seungwon Kim, Steven B. Chinn, Angela Mazul, Shaum S. Sridharan   +11 more
wiley   +1 more source

Molecular reprogramming in thymic neuroendocrine tumors: a narrative review. [PDF]

Mediastinum
Di J, Zhou Y, Hu J.
europepmc   +1 more source

Risk Factors for Cutaneous Immune‐Related Adverse Events in the Japanese Population: A Retrospective Single‐Center Cohort Study

The Journal of Dermatology, EarlyView.
ABSTRACT Immune checkpoint inhibitor (ICI)‐driven alterations in the immune system can induce immune‐related adverse events (irAEs). Cutaneous irAEs are notable for being the most common and for their early onset; however, the risk factors underlying their development and severity remain unclear. In this study, we retrospectively analyzed 1224 Japanese
Tomoya Watanabe, Kohei Yamakawa, Miyu Kobayashi, Yusuke Saigusa, Yukie Yamaguchi   +4 more
wiley   +1 more source